Trexquant Investment LP Spectrum Pharmaceuticals Inc Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$7.03 - $9.7 $102,877 - $141,949	-14,634 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$7.36 - $11.26 $107,706 - $164,778	14,634 New	14,634 $126,000
Q1 2019 May 13, 2019	SELL	$9.08 - $11.84 $91,353 - $119,122	-10,061 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$6.39 - $16.99 $55,739 - $148,203	-8,723 Reduced 46.44%	10,061 $88,000
Q3 2018 Nov 09, 2018	BUY	$16.52 - $24.82 $310,311 - $466,218	18,784 New	18,784 $316,000
Q4 2017 Feb 09, 2018	SELL	$13.36 - $20.73 $425,582 - $660,354	-31,855 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$8.75 - $14.07 $278,731 - $448,199	31,855	31,855 $448,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.